15.42 USD
↗ 0.14 (0.92%)AT CLOSE (11:59 AM EDT)
Design Therapeutics, Inc. Common Stock (DSGN) trades at $15.40 per share. DSGN shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, DSGN trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jul 9, 2026.